WBMD » Topics » Directors

These excerpts taken from the WBMD 10-K filed Apr 30, 2009.
Directors
 
             
Name
 
Age
 
Positions
 
Mark J. Adler, M.D.(3)(4)
    52     Director; Chairman of the Compensation Committee
Neil F. Dimick(1)(2)(4)(5)
    59     Director; Chairman of the Nominating Committee;
Chairman of the Governance & Compliance Committee
Wayne T. Gattinella(1)
    57     Director; Chief Executive Officer and President
Jerome C. Keller
    66     Director
James V. Manning(1)(2)(4)
    62     Director; Chairman of the Audit Committee
Abdool Rahim Moossa, M.D.(3)(5)(6)
    69     Director
Stanley S. Trotman, Jr.(2)(3)(5)(6)
    65     Director; Chairman of the Related Parties Committee
Martin J. Wygod(1)
    69     Chairman of the Board
 
 
(1) Member of the Executive Committee
 
(2) Member of the Audit Committee
 
(3) Member of the Compensation Committee
 
(4) Member of the Governance & Compliance Committee
 
(5) Member of the Nominating Committee
 
(6) Member of the Related Parties Committee
 
For a description of each of the standing committees of the Board of Directors and other corporate governance matters, see “— Corporate Governance” below. Dr. Adler and Messrs. Dimick, Manning and Wygod are also members of the Board of Directors of HLTH which, through its ownership of our Class B Common Stock, owned, as of April 15, 2009, approximately 83.4% of our total outstanding common stock and approximately 95.9% of the combined voting power of our outstanding common stock.
 
Directors


 
































































































             


Name


 


Age


 


Positions

 


Mark J. Adler, M.D.(3)(4)


 
 

52
 

 

Director; Chairman of the Compensation Committee


Neil F. Dimick(1)(2)(4)(5)


 
 

59
 

 

Director; Chairman of the Nominating Committee;

Chairman of the Governance & Compliance Committee


Wayne T. Gattinella(1)


 
 

57
 

 

Director; Chief Executive Officer and President


Jerome C. Keller


 
 

66
 

 

Director


James V. Manning(1)(2)(4)


 
 

62
 

 

Director; Chairman of the Audit Committee


Abdool Rahim Moossa, M.D.(3)(5)(6)


 
 

69
 

 

Director


Stanley S. Trotman, Jr.(2)(3)(5)(6)


 
 

65
 

 

Director; Chairman of the Related Parties Committee


Martin J. Wygod(1)


 
 

69
 

 

Chairman of the Board






 




 
































































(1)

Member of the Executive Committee
 

(2)

Member of the Audit Committee
 

(3)

Member of the Compensation Committee
 

(4)

Member of the
Governance & Compliance Committee
 

(5)

Member of the Nominating Committee
 

(6)

Member of the Related Parties
Committee


 



For a description of each of the standing committees of the
Board of Directors and other corporate governance matters, see
“— Corporate Governance” below.
Dr. Adler and Messrs. Dimick, Manning and Wygod are
also members of the Board of Directors of HLTH which, through
its ownership of our Class B Common Stock, owned, as of
April 15, 2009, approximately 83.4% of our total
outstanding common stock and approximately 95.9% of the combined
voting power of our outstanding common stock.


 




This excerpt taken from the WBMD DEF 14A filed Nov 5, 2008.
Directors
 
             
Name
 
Age
 
Positions
 
Mark J. Adler, M.D.(3)(4)
    52     Director; Chairman of the Compensation Committee
Neil F. Dimick(1)(2)(4)(5)
    59     Director; Chairman of the Nominating Committee; Chairman of the Governance & Compliance Committee
Wayne T. Gattinella(1)
    56     Director; Chief Executive Officer and President
Jerome C. Keller(6)
    66     Director
James V. Manning(1)(2)(4)
    61     Director; Chairman of the Audit Committee
Abdool Rahim Moossa, M.D.(3)(5)(6)
    69     Director
Stanley S. Trotman, Jr.(2)(3)(5)(6)
    65     Director; Chairman of the Related Parties Committee
Martin J. Wygod(1)
    68     Chairman of the Board
 
 
(1) Member of the Executive Committee
 
(2) Member of the Audit Committee
 
(3) Member of the Compensation Committee
 
(4) Member of the Governance & Compliance Committee
 
(5) Member of the Nominating Committee
 
(6) Member of the Related Parties Committee
 
For a description of each of the standing committees of the board of directors and other corporate governance matters, see “Corporate Governance” below. Dr. Adler and Messrs. Dimick, Manning and Wygod are also members of the board of directors of HLTH which, through its ownership of WebMD Class B Common Stock, owns approximately 84% of WebMD’s total outstanding Common Stock and approximately 96% of the combined voting power of WebMD’s outstanding Common Stock as of October 24, 2008.
 
These excerpts taken from the WBMD 10-K filed Apr 29, 2008.
Directors
 
             
Name
 
Age
 
Positions
 
Mark J. Adler, M.D.(3)(4)
    51     Director; Chairman of the Compensation Committee
Neil F. Dimick(1)(2)(4)(5)
    58     Director; Chairman of the Nominating Committee; Chairman of the Governance & Compliance Committee
Wayne T. Gattinella(1)
    56     Director; Chief Executive Officer and President
Jerome C. Keller
    65     Director
James V. Manning(1)(2)(4)
    61     Director; Chairman of the Audit Committee
Abdool Rahim Moossa, M.D.(3)(5)(6)
    68     Director
Stanley S. Trotman, Jr.(2)(3)(5)(6)
    64     Director; Chairman of the Related Parties Committee
Martin J. Wygod(1)
    68     Chairman of the Board
 
 
(1) Member of the Executive Committee
 
(2) Member of the Audit Committee
 
(3) Member of the Compensation Committee
 
(4) Member of the Governance & Compliance Committee
 
(5) Member of the Nominating Committee
 
(6) Member of the Related Parties Committee
 
For a description of each of the standing committees of the Board of Directors and other corporate governance matters, see “— Corporate Governance” below. Dr. Adler and Messrs. Dimick, Manning and Wygod are also members of the Board of Directors of HLTH which, through its ownership of our Class B Common Stock, owns approximately 83.4% of our total outstanding common stock and approximately 96.2% of the combined voting power of our outstanding common stock as of April 15, 2008.
 
Directors


 
































































































             


Name


 


Age


 


Positions

 


Mark J. Adler, M.D.(3)(4)


 
 

51
 

 

Director; Chairman of the Compensation Committee


Neil F. Dimick(1)(2)(4)(5)


 
 

58
 

 

Director; Chairman of the Nominating Committee; Chairman of the
Governance & Compliance Committee


Wayne T. Gattinella(1)


 
 

56
 

 

Director; Chief Executive Officer and President


Jerome C. Keller


 
 

65
 

 

Director


James V. Manning(1)(2)(4)


 
 

61
 

 

Director; Chairman of the Audit Committee


Abdool Rahim Moossa, M.D.(3)(5)(6)


 
 

68
 

 

Director


Stanley S. Trotman, Jr.(2)(3)(5)(6)


 
 

64
 

 

Director; Chairman of the Related Parties Committee


Martin J. Wygod(1)


 
 

68
 

 

Chairman of the Board






 




 
































































(1)

Member of the Executive Committee
 

(2)

Member of the Audit Committee
 

(3)

Member of the Compensation Committee
 

(4)

Member of the
Governance & Compliance Committee
 

(5)

Member of the Nominating Committee
 

(6)

Member of the Related Parties
Committee


 



For a description of each of the standing committees of the
Board of Directors and other corporate governance matters, see
“— Corporate Governance” below.
Dr. Adler and Messrs. Dimick, Manning and Wygod are
also members of the Board of Directors of HLTH which, through
its ownership of our Class B Common Stock, owns
approximately 83.4% of our total outstanding common stock and
approximately 96.2% of the combined voting power of our
outstanding common stock as of April 15, 2008.


 




This excerpt taken from the WBMD DEF 14A filed Aug 14, 2007.
Directors
 
             
Name
 
Age
 
Positions
 
Mark J. Adler, M.D.(3)(4)
  50   Director; Chairman of the Compensation Committee
Neil F. Dimick(1)(2)(4)(5)
  58   Director; Chairman of the Nominating Committee; Chairman of the Governance & Compliance Committee
Wayne T. Gattinella(1)
  55   Director; Chief Executive Officer and President
Jerome C. Keller
  65   Director
James V. Manning(1)(2)(4)
  60   Director; Chairman of the Audit Committee
Abdool Rahim Moossa, M.D.(3)(5)(6)
  67   Director
Stanley S. Trotman, Jr.(2)(3)(5)(6)
  64   Director; Chairman of the Related Parties Committee
Martin J. Wygod(1)
  67   Chairman of the Board
 
 
(1) Member of the Executive Committee
 
(2) Member of the Audit Committee
 
(3) Member of the Compensation Committee
 
(4) Member of the Governance & Compliance Committee
 
(5) Member of the Nominating Committee
 
(6) Member of the Related Parties Committee
 
For a description of each of the standing committees of the Board of Directors and other corporate governance matters, see “Corporate Governance” below. Dr. Adler and Messrs. Dimick, Manning and Wygod are also members of the Board of Directors of HLTH which, through its ownership of our Class B Common Stock, owns approximately 84% of our total outstanding common stock and approximately 96% of the combined voting power of our outstanding Common Stock.
 
This excerpt taken from the WBMD 10-K filed Apr 30, 2007.
Directors
 
             
Name
 
Age
 
Positions
 
Mark J. Adler, M.D.(3)(4)
  50   Director; Chairman of the Compensation Committee
Neil F. Dimick(1)(2)(4)(5)
  57   Director; Chairman of the Nominating Committee; Chairman of the Governance & Compliance Committee
Wayne T. Gattinella(1)
  55   Director; Chief Executive Officer and President
Jerome C. Keller
  64   Director
James V. Manning(1)(2)(4)
  60   Director; Chairman of the Audit Committee
Abdool Rahim Moossa, M.D.(3)(5)(6)
  67   Director
Stanley S. Trotman, Jr.(2)(3)(5)(6)
  63   Director; Chairman of the Related Parties Committee
Martin J. Wygod(1)
  67   Chairman of the Board
 
 
(1) Member of the Executive Committee
 
(2) Member of the Audit Committee
 
(3) Member of the Compensation Committee
 
(4) Member of the Governance & Compliance Committee
 
(5) Member of the Nominating Committee
 
(6) Member of the Related Parties Committee
 
For a description of each of the standing committees of the Board of Directors and other corporate governance matters, see “— Corporate Governance” below. Dr. Adler and Messrs. Dimick, Manning and Wygod are also members of the Board of Directors of Emdeon which, through its ownership of our Class B Common Stock, owns approximately 84% of our total outstanding common stock and approximately 96% of the combined voting power of our outstanding common stock.
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki